Ibnsina-Pharma is committed to solidifying and growing its legacy pharmaceutical distribution business through building a highly efficient supply chain and utilizing advanced technologies to provide the highest standard of services to clients. Ibnsina-pharma's competitive advantage over new entrants is economies of scale, with over 9,500 SKUs, 50k customers, over 800 distribution vehicles, and a 7K person strong team.
Ibnsina-Pharma seeks to establish sustainable, value-based differentiation in the market as it focuses on resource allocation to maximize value. It funnels considerable time, energy, and manpower to provide its highest-value clients with a comprehensive portfolio of services beyond its core business of distribution. This has allowed the company to grow considerably faster than competitors, as it daily delivers a high volume of transactions to a large number of suppliers and end consumers. Ibnsina-Pharma’s growth has outpaced the market by over twofold for the last five years, with a CAGR in revenues of 31% compared to an industry CAGR of 17%.
Because Ibnsina-Pharma believes that diversified revenue streams largely mitigate the risks for any organization, the company has built up a solid, well-rounded foundation to give it the know-how, assets, systems, and ability to handle complex operations that can be leveraged across industries. Its highly efficient supply chain, expansive distribution network, and third-party logistics activities (warehousing, transportation, overprinting, relabeling, and repackaging) that will allow it to reap long-term benefits from the expansion into higher-margin, diversified revenue streams.